Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Biosimilars: This Decade's Most Disruptive Technology
PharmExec
Thursday, September 23, 2010 - 9:40am
tags:
biosimilars
Third Rock leads $30M round for antibody upstart CytomX
Fierce Biotech
Thursday, September 23, 2010 - 7:55am
tags:
CytomX, venture capital, antibodies
House Passes Bill To Ban Execs For Healthcare Fraud
Pharmalot
Thursday, September 23, 2010 - 7:51am
tags:
healthcare fraud, healthcare reform
Global CRO market grows 13% in 2009 but profits squeezed
Pharma Times, UK
Thursday, September 23, 2010 - 7:25am
tags:
CROs
Notes From PSA: More on Lilly's Next Project Financing Project
InVivo
Thursday, September 23, 2010 - 7:19am
tags:
Eli Lilly, financing, Alzheimer's disease
Will Endo Pharmaceuticals Holdings Whiff on Revenues Next Quarter?
Motley Fool
Thursday, September 23, 2010 - 6:54am
tags:
Endo, earnings
Celera and Abbott Signs a Deal
Yahoo/Zacks.com
Thursday, September 23, 2010 - 6:53am
tags:
Celera, Abbott Laboratories
A Dendreon Deal: It's Not What You Think
Motley Fool
Wednesday, September 22, 2010 - 3:48pm
tags:
Dendreon, GSK, Provenge, prostate cancer
Lundbeck Is The Latest To Cut Jobs & Shift R&D
Pharmalot
Wednesday, September 22, 2010 - 3:42pm
tags:
R&D, layoffs, Lundbeck
J&J lawyers: FDA knew of secret 2009 Motrin recall
Yahoo/AP
Wednesday, September 22, 2010 - 3:40pm
tags:
Motrin, FDA, JNJ, recalls
Abbott recalls infant formula on bug contamination
Abbott
Wednesday, September 22, 2010 - 2:13pm
tags:
infant formula, Abbott Laboratories, recalls
Professional Pharmaceutical Representative Compensation
Pharmareform
Wednesday, September 22, 2010 - 1:28pm
tags:
drug reps
Sanofi May Announce ‘Critical’ Diabetes Partnerships
Bloomberg
Wednesday, September 22, 2010 - 1:27pm
tags:
Sanofi, diabetes, partnerships
Endo pain drug formulation gets FDA priority review
Bizjournals.com
Wednesday, September 22, 2010 - 1:25pm
tags:
oxymorphone, FDA, Endo
Bristol-Myers To Pay $27M For Illegal Pricing
Pharmalot
Wednesday, September 22, 2010 - 11:42am
tags:
Bristol-Myers Squibb, settlements, Medicaid
Dendreon: Assessing New Threat to Provenge
TheStreet.com
Wednesday, September 22, 2010 - 11:40am
tags:
Provenge, Dendreon, vaccines, prostate cancer, AstraZeneca, zibotentan
Vical shares crushed by failed drug trial
Marketwatch
Wednesday, September 22, 2010 - 11:39am
tags:
Vical
Drug indexes gain as Biogen Idec slides
Marketwatch
Wednesday, September 22, 2010 - 11:38am
tags:
Biogen Idec, drug stocks
Will Johnson & Johnson Turnover Documents Today?
Pharmalot
Wednesday, September 22, 2010 - 10:09am
tags:
JNJ, recalls
Teva files new Copaxone lawsuit against Mylan
Yahoo/AP
Wednesday, September 22, 2010 - 10:08am
tags:
Teva Pharmaceuticals, Copaxone, patents, generics, MS, multiple sclerosis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.